Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Azidus Brasil clinical trials
Also known as AZD CRO.
The registry lists 80 studies whose lead sponsor is Azidus Brasil. 5 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 3, 2026.
Keep track of what changes. Save the Azidus Brasil studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesWhere
- Brazil
- 65
Registry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Azidus Brasil.
- Azidus Brasil80 studiesSame company
Something wrong?
Focus areas
Conditions Azidus Brasil leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 80. Browse all 80 →
- IVIG Boya: Safety, Efficacy, and PharmacokineticsNot yet recruitingNCT06150833Phase 3
- Efficacy and Safety of Nitazoxanide 600 Mg in the Outpatient Treatment of COVID-19 and InfluenzaNot yet recruitingNCT06817096Phase 3
- Efficacy, Safety, and Pharmacokinetics of Shu Yang IVIGNot yet recruitingNCT06089122Phase 3
- Safety of UFRJvac, Trivalent COVID-19 VaccineNot yet recruitingNCT06303635
- Efficacy and Safety of NestaCell® in Huntington's DiseaseNot yet recruitingNCT06097780Phase 3
- Dose-response Evaluation of the Cellavita HD Product in Patients With Huntington's DiseaseCompletedNCT03252535Phase 2
- Efficacy And Safety Of Probiatop In The Treatment Of Digestive SymptomsCompletedNCT05603403Phase 4
- Efficacy and Safety of Hydroxychloroquine and Azithromycin for Patients With Moderate to Severe COVID-19SuspendedNCT04329572Early Phase 1
- Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Ambulatory Patients With Mild COVID-19SuspendedNCT04348474Early Phase 1
- Non-inferiority Clinic of Kollagenase® Compared Iruxol® in Treatment of Cutaneous UlcersSuspendedNCT00701974Phase 2/3
- Pharmacodynamics Of Product Octreotide Acetate Lar 30 Mg Compared To Product Sandostatin LAR ®SuspendedNCT01086982Phase 1
- Safe Use of Heparin Sodium in Patients With Chronic Renal Failure.SuspendedNCT01229072Phase 2/3
- Effectiveness of Pancreatic Enzymes in Patients Pancreatic Insufficient: Comparison of Two DrugsWithdrawnNCT01228643Phase 3
- Sodic Heparin Effectiveness of the Treatment of BurnsWithdrawnNCT00701623Phase 2/3
- Efficiency And Safety Of Association Arbutin, Triamcinolone And Tretinoin In Treatment Of MelasmaSuspendedNCT00717652Phase 2/3
- Effectiveness of Association Mometasone Furoate 0.1% and Salicylic Acid 5% Compared With Mometasone FuroateSuspendedNCT01228656Phase 2
- Efficacy and Comparative of the Association Beclomethasone Clotrimzaol + Gentamicin in Patients With Acne ContaminatedSuspendedNCT01244256Phase 2/3
- Efficacy and Safety of the Association Drugs in Patients With Allergic DermatitisWithdrawnNCT01125761Phase 3
- Pharmacokinetics and Pharmacodynamics Assessment of Drug Eritromax Compared to Eprex in Healthy Subjects.CompletedNCT03572647Phase 1
- Clinical Efficacy of the Drug Ster® Compared With Predfort® in Control of Postoperative Inflammation in Cataract SurgeryCompletedNCT01227876Phase 3
- Clinical Efficacy of Postpartum Immunization of Rh and Coombs Negative Women With Sensitization Risk.SuspendedNCT01666249Phase 3
- Safety Evaluation of Cellavita HD Administered Intravenously in Participants With Huntington's DiseaseStatus unknownNCT02728115Phase 1
- Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Subcutaneous Single DoseCompletedNCT01692158Phase 1
- Clinical Assessment Of Association Pharmacokinetics Atorvastatin + Losartana + HydrochlorothiazideCompletedNCT01692717Phase 1
- Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Intravenous AdministrationCompletedNCT01692171Phase 1
- Efficacy and Safety of Nitazoxanide 600 mg BID Versus Placebo for the Treatment of Hospitalized Patients With COVID-19Status unknownNCT04423861Phase 3
- Clinical Trial Of The Effectiveness Of The Product Cloratadd D (Loratadine + Pseudoephedrine Sulfate) Produced By The Laboratory EMS S/A, Compared To The Drug Claritin D Produced By Schering-Plough S/A, In Patients With Allergic RhinitisWithdrawnNCT01055756Phase 3
- PK and PD Crossover Study After Single Dose, Intravenous Administration of Two Epoetin Alfa, Human Recombinant Epoetin and Eprex, in Healthy Subjects.CompletedNCT01685333Phase 1
- Clinical Extension Study for Safety and Efficacy Evaluation of Cellavita-HD Administration in Huntington's Patients.Status unknownNCT04219241Phase 2/3
- Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19WithdrawnNCT04435314Phase 2
- PK and PD Parallel Study After Multiple Dose, Intravenous Administration of Two Epoetin Alfa, Human RecombinantCompletedNCT01685359Phase 1
- NestaCell® Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 PneumoniaCompletedNCT04315987Phase 2
- Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19CompletedNCT04348409Not applicable
- Efficacy and Safety of Nitazoxanide 600 mg to Treat Mild Ambulatory COVID-19 PatientsWithdrawnNCT04441398Phase 2/3
- Study To Evaluate The Sensitivity Of The Linda Thermal DeviceStatus unknownNCT05009277
- Safety and Immunogenicity of the RNA MCTI CIMATEC HDT VaccineStatus unknownNCT05542693Phase 2
- Efficacy and Safety of MTX-loaded Nanoparticles to Treat Severe COVID-19 PatientsStatus unknownNCT04352465Phase 1/2
- Clinical Efficacy of Two Erythropoietin Drug in Participants With Secondary Anemia to Chronic Kidney Disease.TerminatedNCT01695759Phase 3
- Evaluation of Pharmacokinetic and Pharmacodynamic Parameters of Filgrastim (G-CSF)Produced by Blausiegel Indústria e Comércio Ltda. Compared to Granulokine Produced by Produtos Roche Químicos e Farmacêuticos S/A.CompletedNCT01549301Phase 1
- Effectiveness of Two Preparations of Loratadine + Pseudoephedrine in Patients With Perennial Allergic Rhinitis.CompletedNCT01228630Phase 3
- Efficacy and Safety of a New Botulinum Toxin Type A for Treatment of Facial Expression LinesCompletedNCT01180348Phase 3
- Evaluation of Ciclo 21® Effect (Levonorgestrel + Ethinyl Estradiol) Compared to Nordette®.CompletedNCT01480778Phase 3
- Efficacy of Sodium Heparin in Prophylaxis of Venous Thromboembolism in Surgical PatientsWithdrawnNCT00912483Phase 3
- Effectiveness of Glucosamine + Chondroitin in OsteoarthrosisCompletedNCT00860873Phase 3
- Efficacy and Safety of Sodium Heparin (Hipolabor) in PatientsCompletedNCT00894673Phase 3
- Efficacy and Safety of Sodium Heparin (Eurofarma)CompletedNCT00894829Phase 3
- Efficacy and Safety of Sodium Heparin in PatientsCompletedNCT00894959Phase 3
- Efficacy and Safety of Sodium HeparinCompletedNCT00894985Phase 3
- Efficacy of the Combination Bismuth + Neomycin + Procaine in the Treatment of Recurrent Aphthous UlcerationCompletedNCT00857688Phase 3
- Pharmacokinetics and Pharmacodynamics of the Interferon Beta-1a Produced by Laboratorio Quimico Farmaceutico Bergamo Compared to Interferon Beta-1a (Rebif - Merck Serono) in Healthy SubjectsCompletedNCT01074593Phase 1